Table 3.
Descriptive analysis and Comparison of Secondary Outcomes
| Variable | Thrombocytopenic Group (n = 155) | Control Group (n = 310) | Estimate (OR or mean difference) | 95% CI | p value |
|---|---|---|---|---|---|
| Blood transfusion | 5 (3.2%) | 7 (2.3%) | 1.55 | 0.43–5.58 | 0.505 |
| Visually estimated blood loss | 315.8 ± 150.0 | 297.6 ± 126.6 | 18.23 | −7.07-43.52 | 0.158 |
| Hemostatic therapy | 0 (0%) | 0 (0%) | / | / | / |
| Adverse event | 2 (1.3%) | 2 (0.65%) | 2.00 | 0.28–14.20 | 0.488 |
| ICU stay | 12 (7.7%) | 2 (0.65%) | 12.00 | 2.69–53.62 | 0.001a |
| Length of hospital stay | 3 [3,4] | 3 [3,4] | 0.40 | 0.09–0.71 | 0.011a |
| All-cause mortality | 0 (0%) | 0 (0%) | / | / | / |
Abbreviations: ICU intensive care unit, OR odds ratio, CI confidence interval;
Continuous data was expressed as mean (SD) (normally distributed data) or median (quartiles) (non-normally distributed data. Categorical data was expressed as number (percentage). Visually estimated blood loss and the length of postoperative hospital stay was compared by mixed-effect model. Other parameters were compared by conditional logistic regression. a Significant difference